{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:01:18Z","timestamp":1788415278857,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.toxlet.2022.06.009","type":"journal-article","created":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T19:40:30Z","timestamp":1656877230000},"page":"26-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The relative efficacy of chemically diverse small-molecule enzyme-inhibitors against anticoagulant activities of Black Snake (Pseudechis spp.) venoms"],"prefix":"10.1016","volume":"366","author":[{"given":"Abhinandan","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Youngman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca W.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan G.","family":"Fry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2022.06.009_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-19981-6","article-title":"A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite","volume":"11","author":"Albulescu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxlet.2022.06.009_bib2","doi-asserted-by":"crossref","unstructured":"Bittenbinder, M.A., Zdenek, C.N., op den Brouw, B., Youngman, N.J., Dobson, J.S., Naude, A., Vonk, F.J., & Fry, B.G., 2018, Coagulotoxic cobras: clinical implications of strong anticoagulant actions of African spitting Naja venoms that are not neutralised by antivenom but are by LY315920 (varespladib). Toxins (Basel). 10, 516 https:\/\/doi.org\/10.3390\/toxins10120516.","DOI":"10.3390\/toxins10120516"},{"key":"10.1016\/j.toxlet.2022.06.009_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4320175","article-title":"Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite","volume":"2018","author":"Bulfone","year":"2018","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.toxlet.2022.06.009_bib4","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1021\/pr0701714","article-title":"Snake venomics of Bitis species reveals large intragenus venom toxin composition variation: application to taxonomy of congeneric taxa","volume":"6","author":"Calvete","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.toxlet.2022.06.009_bib5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1021\/pr060494k","article-title":"Snake venomics of Bitis gabonica gabonica. Protein family composition, subunit organization of venom toxins, and characterization of dimeric disintegrins bitisgabonin-1 and bitisgabonin-2","volume":"6","author":"Calvete","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.toxlet.2022.06.009_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tree.2012.10.020","article-title":"Complex cocktails: The evolutionary novelty of venoms","volume":"28","author":"Casewell","year":"2013","journal-title":"Trends Ecol. Evol."},{"key":"10.1016\/j.toxlet.2022.06.009_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.752442","article-title":"The relative efficacy of chemically diverse small-molecule enzyme-inhibitors against anticoagulant activities of african spitting cobra (Naja Species) venoms","volume":"12","author":"Chowdhury","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxlet.2022.06.009_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.toxlet.2020.12.019","article-title":"Clinical implications of differential procoagulant toxicity of the palearctic viperid genus Macrovipera, and the relative neutralization efficacy of antivenoms and enzyme inhibitors","volume":"340","author":"Chowdhury","year":"2021","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2022.06.009_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.688802","article-title":"Venom-Induced Blood Disturbances by Palearctic Viperid Snakes, and Their Relative Neutralization by Antivenoms and Enzyme-Inhibitors","volume":"12","author":"Chowdhury","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxlet.2022.06.009_bib10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.5694\/j.1326-5377.2010.tb04108.x","article-title":"Clinical effects of red-bellied black snake (Pseudechis porphyriacus) envenoming and correlation with venom concentrations: Australian Snakebite Project (ASP-11)","volume":"193","author":"Churchman","year":"2010","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.toxlet.2022.06.009_bib11","doi-asserted-by":"crossref","unstructured":"Cogger, H.G., 2014, Family Elapidae (Elapid Snakes).Pages 29\u201330 in Reptiles and amphibians of Australia. 7th ed. CSRIO, Victoria.","DOI":"10.1071\/9780643109773"},{"key":"10.1016\/j.toxlet.2022.06.009_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.toxicon.2015.12.017","article-title":"Characterization and structural analysis of a potent anticoagulant phospholipase A2 from Pseudechis australis snake venom","volume":"111","author":"Du","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.toxlet.2022.06.009_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cbpc.2018.01.001","article-title":"Proteomic and functional variation within black snake venoms (Elapidae: Pseudechis)","volume":"205","author":"Goldenberg","year":"2018","journal-title":"Comp. Biochem. Physiol. Part C. Toxicol. Pharmacol."},{"key":"10.1016\/j.toxlet.2022.06.009_bib14","first-page":"1","article-title":"Snakebite envenoming","volume":"3","author":"Guti\u00e9rrez","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.toxlet.2022.06.009_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biologicals.2011.02.005","article-title":"Antivenoms for the treatment of snakebite envenomings: The road ahead","volume":"39","author":"Guti\u00e9rrez","year":"2011","journal-title":"Biologicals"},{"key":"10.1016\/j.toxlet.2022.06.009_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins12020131","article-title":"Varespladib (LY315920) and Methyl Varespladib (LY333013) abrogate or delay lethality induced by presynaptically acting neurotoxic snake venoms","volume":"12","author":"Guti\u00e9rrez","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.toxlet.2022.06.009_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.toxicon.2010.04.018","article-title":"Regional divergence of phospholipase A2-like protein cDNAs between New Guinean and Australian Pseudechis australis","volume":"56","author":"Inagaki","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.toxlet.2022.06.009_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/qjmed\/hcl007","article-title":"Collett\u2019s snake (Pseudechis colletti) envenoming in snake handlers","volume":"99","author":"Isbister","year":"2006","journal-title":"QJM Int. J. Med"},{"key":"10.1016\/j.toxlet.2022.06.009_bib19","first-page":"1","article-title":"Phospholipase A2 (PLA2) as an Early Indicator of Envenomation in Australian Elapid Snakebites (ASP-27)","volume":"459 8","author":"Isbister","year":"2020","journal-title":"Biomed. 2020, Vol. 8"},{"key":"10.1016\/j.toxlet.2022.06.009_bib20","unstructured":"James, T., 2018, Australian Snakebite and Treatment.Pages 196\u201397 in Clinical Toxinology in Australia, Europe, and Americas, Toxinology. Gopalakrishnakone, P., ed. Springer Nature."},{"key":"10.1016\/j.toxlet.2022.06.009_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5694\/j.1326-5377.2007.tb00788.x","article-title":"Spotted black snake (Pseudechis guttatus) envenoming","volume":"186","author":"Jansen","year":"2007","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.toxlet.2022.06.009_bib22","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1371\/journal.pmed.0050218","article-title":"The global burden of snakebite: A literature analysis and modelling based on regional estimates of envenoming and deaths","volume":"5","author":"Kasturiratne","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.toxlet.2022.06.009_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/toxins13050302","article-title":"Anticoagulant activity of Naja nigricollis venom is mediated by phospholipase A2 toxins and inhibited by varespladib","volume":"13","author":"Kazandjian","year":"2021","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.toxlet.2022.06.009_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/abbi.1999.1345","article-title":"Targeting of venom phospholipases: The strongly anticoagulant phospholipase A2 from Naja nigricollis venom binds to coagulation factor Xa to inhibit the prothrombinase complex","volume":"369","author":"Kerns","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.toxlet.2022.06.009_bib25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.toxicon.2005.02.018","article-title":"Structure-function relationships and mechanism of anticoagulant phospholipase A2 enzymes from snake venoms","volume":"45","author":"Kini","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.toxlet.2022.06.009_bib26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/BJ20060302","article-title":"Anticoagulant proteins from snake venoms: Structure, function and mechanism","volume":"397","author":"Kini","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxlet.2022.06.009_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0041-0101(94)90371-9","article-title":"Neurotoxicity and haemostatic disturbances in patients envenomed by the Papuan black snake (Pseudechis papuanus)","volume":"32","author":"Lalloo","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.toxlet.2022.06.009_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.toxicon.2011.05.020","article-title":"Coagulant effects of black snake (Pseudechis spp.) venoms and in vitro efficacy of commercial antivenom","volume":"58","author":"Lane","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.toxlet.2022.06.009_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins10110479","article-title":"Delayed LY333013 (oral) and LY315920 (intravenous) reverse severe neurotoxicity and rescue juvenile pigs from lethal doses of Micrurus fulvius (eastern coral snake) venom","volume":"10","author":"Lewin","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.toxlet.2022.06.009_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.toxicon.2016.04.006","article-title":"Varespladib (LY315920) appears to be a very potent, broad-spectrum, inhibitor of snake venom PLA2s from six continents","volume":"117","author":"Lewin","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.toxlet.2022.06.009_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins8090248","article-title":"Varespladib (LY315920) appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation","volume":"8","author":"Lewin","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.toxlet.2022.06.009_bib32","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0041-0101(00)00102-1","article-title":"The envenomation syndrome caused by the Australian Red-bellied Black Snake Pseudechis porphyriacus","volume":"38","author":"Pearn","year":"2000","journal-title":"Toxicon"},{"key":"10.1016\/j.toxlet.2022.06.009_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.toxicon.2014.04.003","article-title":"The Australian mulga snake (Pseudechis australis: Elapidae): Report of a large case series of bites and review of current knowledge","volume":"85","author":"Razavi","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.toxlet.2022.06.009_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.612846","article-title":"A Clot Twist: Extreme Variation in Coagulotoxicity Mechanisms in Mexican Neotropical Rattlesnake Venoms","volume":"12","author":"Seneci","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxlet.2022.06.009_bib35","series-title":"Group I phospholipase A2 enzymes.Pages 327\u2013334 in Venomous Reptiles and their Toxins: Evolution, Pathophysiology and Biodiscovery","author":"Sunagar","year":"2015"},{"key":"10.1016\/j.toxlet.2022.06.009_bib36","series-title":"Australian Animal Toxins: The Creatures, Their Toxins, and Care of the Poisoned Patient","author":"Sutherland","year":"1983"},{"key":"10.1016\/j.toxlet.2022.06.009_bib37","first-page":"23","article-title":"Exploration of the inhibitory potential of varespladib for snakebite envenomation","author":"Wang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.toxlet.2022.06.009_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines8060165","article-title":"Varespladib inhibits the phospholipase A2 and coagulopathic activities of venom components from haemotoxic snakes","volume":"8","author":"Xie","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.toxlet.2022.06.009_bib39","first-page":"1","article-title":"Utilising venom activity to infer dietary composition of the Kenyan horned viper (Bitis worthingtoni). Comp. Biochem","volume":"240","author":"Youngman","year":"2021","journal-title":"Physiol. Part - C. Toxicol. Pharm."},{"key":"10.1016\/j.toxlet.2022.06.009_bib40","first-page":"236","article-title":"Varespladib (LY315920) neutralises phospholipase A 2 mediated prothrombinase-inhibition induced by Bitis snake venoms","author":"Youngman","year":"2020","journal-title":"Comp. Biochem. Physiol. Part C."},{"key":"10.1016\/j.toxlet.2022.06.009_bib41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.toxlet.2020.05.014","article-title":"Anticoagulant activity of black snake (Elapidae: Pseudechis) venoms: Mechanisms, potency, and antivenom efficacy","volume":"330","author":"Zdenek","year":"2020","journal-title":"Toxicol. Lett."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427422001357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427422001357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:26:11Z","timestamp":1759901171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427422001357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":41,"alternative-id":["S0378427422001357"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2022.06.009","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relative efficacy of chemically diverse small-molecule enzyme-inhibitors against anticoagulant activities of Black Snake (Pseudechis spp.) venoms","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2022.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}